A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02472548 |
Recruitment Status :
Completed
First Posted : June 16, 2015
Last Update Posted : February 5, 2020
|
Sponsor:
Dalhousie University
Collaborator:
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Information provided by (Responsible Party):
Joanne Langley, Dalhousie University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | March 14, 2017 |
Actual Study Completion Date : | March 14, 2017 |